A middle-aged woman sustained serious heart valve injury (i.e.
primary pulmonary hypertension) from taking a prescribed diet drug
Redux, which contains Fen/Phen. Our firm maintained joint responsibility with an experienced drug injury
firm who settled the case.
$2.5 Million Settlement
A wife and mother of two children died of a cerebral hemorrhage
after taking an over the counter diet drug diet drug containing
Ephedra. The deceased’s husband contacted our firm for help.
Our firm maintained joint responsibility with an experienced product liability attorney who settled
the case.
$900,000 Settlement
We were co-counsel in a case involving a dietary supplement with
PPA. The client suffered a stroke and had a brain bleed that required
two surgeries. Our firm maintained joint responsibility with an experienced product liability attorney
who settled the case.
$ 750,000 Settlement
A teenager committed suicide after taking an anti-depressant drug
for several weeks. The young boy’s life was cut short just
one week before his birthday. Our firm maintained joint responsibility with an experienced product liability
attorney who settled the case.
$1.25 Million Settlement
Our client was the mother of a one year old child who was born with a complex cardiovascular condition. The child was diagnosed with arterial septal defect, ventricular septal defect and congestive heart failure, all conditions caused by the mother's use of Paxil during the first trimester of her pregnancy. Our firm maintained joint responsibility with an experienced drug injury firm who settled the case.
$800,000 Settlement
When Baycol was removed from the market in 2001, we were contacted by many Rhode Islanders who were injured by this medication. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, who was successful in negotiating a multi-million dollar settlement for several clients.
$2 Million in total Settlements
Due to taking the drug zyprexa, a number of our clients developed type 2 diabetes as a side effect. Our firm maintained joint responsibility with a pharmaceutical litigation law firm, who was successful in negotiating a multi-million dollar settlement for our clients.
$3.8 Million in total
Settlements
A Connecticut man was diagnosed with Type II diabetes after using the medication, Zyprexa. Our firm maintained joint responsibility with an experienced attorney in pharmaceutical litigation, and the case was settled out of court.
$500,000 Settlement

Expectant mothers who have taken or are taking antidepressants may unknowingly be harming their developing babies. Researchers have begun to identify a possible link between the antidepressant drug Wellbutrin, and an increased risk of cardiac birth defects.
Wellbutrin, which is manufactured by GlaxoSmithKline, is used to treat depression. It was FDA approved in December 1985. In May 2010 reports surfaced in the American Journal of Obstetrics & Gynecology indicating that approximately two out of every 1,000 women who took Wellbutrin during the first trimester of their pregnancy faced an increased risk of their child developing cardiac birth defects.
The study included reports pertaining to the observation of more than 12,700 babies born in the U.S. between 1997 and 2004. The research team observed data from 5,869 infants who had no birth defects, and 6,853 infants born with a major heart defect. Such data indicated that of those babies born with a heart defect, 0.5 percent of the mothers reported using Wellbutrin during the month prior to pregnancy or in their first trimester. Researchers also found that babies born to mothers who took Wellbutrin in early pregnancy experienced more than double the risk for specific heart defects as compared to babies whose mothers did not take the drug.
The risk that researchers have identified as associated with Wellbutrin is a left outflow tract defect which causes interference of the blood flow from the left chamber of the heart to the remaining areas of the body. Often, the defect causes a narrowing of the body’s main artery. Such a defect often requires surgical repair.
PLEASE SPEAK WITH YOUR DOCTOR BEFORE DISCONTINUING THE USE OF WELLBUTRIN OR ANY OTHER PRESCRIPTION DRUGS.
If you believe that your child has developed a birth defect due to exposure to the antidepressant Wellbutrin during pregnancy, you may want to speak with a personal injury attorney today, regarding your potential lawsuit. An injury lawyer familiar with new developments in the investigation of Wellbutrin may be able to help you make important personal and legal decisions.
Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.